Vimarsana
Biggest News Aggregation in the World

Page 35 - Preferred Reporting Items News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preferred Reporting Items. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preferred Reporting Items Today - Breaking & Trending Today

Cureus | Obesity and Coronary Artery Disease: An Updated Systematic Review 2022 - Vimarsana News

Cureus | Obesity and Coronary Artery Disease: An Updated Systematic Review 2022

The primary goal is to identify the pathogenesis of cardiovascular illnesses in obese patients. Articles were extracted using the MeSH search approach from PubMed and Google Scholar databases. Inclusion and exclusion criteria were used, and duplicates were eliminated. Eight publications were finally included in this research study after two authors independently completed the quality check appraisal. Seven observational studies and one narrative review were found in our search. The publications evaluated the risk of coronary artery disease in metabolically healthy obese people with that of unh...

Source: cureus.com
Cureus | Comparing the Effectiveness of Honey Consumption With Anti-Cough Medication in Pediatric Patients: A Systematic Review - Vimarsana News

Cureus | Comparing the Effectiveness of Honey Consumption With Anti-Cough Medication in Pediatric Patients: A Systematic Review

Coughing is one of the most prevalent symptoms in children presenting at outpatient departments. This systematic review aimed to review previous literature in order to compare the use of honey and antitussive medications for treating coughs in children. Literature was screened across five databases using Medical Subject Heading (MeSH) strategy, keywords, and inclusion and exclusion criteria. The remaining literature was evaluated using a quality appraisal tool checklist. This review includes systematic reviews, ‎‎meta-analyses, randomized controlled trials (RCTs), observational studies, cr...

Source: cureus.com
Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011 | BMC Medicine - Vimarsana News

Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011 | BMC Medicine

Non-communicable diseases (NCDs) are a leading cause of maternal mortality and morbidity worldwide. The World Health Organization is developing new recommendations focusing on the management of NCDs for pregnant, intrapartum, and postnatal women. Thus, to support the development of new guidelines and recommendations, we aimed to determine the availability, focus, and scope of recommendations of current guidelines for the management of NCDs during pregnancy, intrapartum, and postnatal period. PubMed, Global Index Medicus, TRIP, and Guideline International Network databases were searched on 31 M...

Cureus | The Multidisciplinary Management of Perianal Fistulas in Crohn's Disease: A Systematic Review - Vimarsana News

Cureus | The Multidisciplinary Management of Perianal Fistulas in Crohn's Disease: A Systematic Review

Perianal fistulas in Crohn's disease (CD) are often recurring and challenging to treat. This systematic review aimed to evaluate the medical, surgical, and combination treatment options and provide an overview of their efficacy. We performed this systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Our group searched PubMed, Medline, PubMed Central, Google Scholar, and ScienceDirect for articles within the last ten years using different terms and criteria mentioned in detail in the search strategy and eligibility criteria ...

Source: cureus.com
Time to Test Effects of CBD in Cardiovascular Disease? - Vimarsana News

Time to Test Effects of CBD in Cardiovascular Disease?

Preclinical evidence suggests that it's time for well-designed clinical trials to test the safety and efficacy of cannabidiol in the management of acute and chronic coronary syndromes, researchers say.